The Top Ten Health Mutual Funds

0
34
These Are The Top Ten Health Mutual Funds

Pharmaceutical and healthcare stocks are thought to be evergreen, but they have underperformed for the past four to five years. Following the coronavirus epidemic last year, the industry was thrust back into the spotlight.

Now, for at least the next couple of years, this industry is predicted to outperform, making it an appealing investment prospect. Mutual funds are a convenient method to invest in pharmaceutical and healthcare businesses. If you’re considering investing in such firms, the top ten health mutual funds are listed below to assist you in making your decision.

Top Ten Health Mutual Funds

We evaluated their previous one-year return statistics to come up with the top 10 health mutual funds (from U.S. News). The top 10 mutual funds for health are shown below:

10. VALIC Company I Health Sciences Fund (VCHSX, 49%)

The VCHSX invests in the common stocks of companies that are involved in the research, development, manufacture, or distribution of health-related products or services. In the previous three years, this fund has returned 18.35 percent, and in the previous five years, it has returned 16.90 percent. The total assets of VCHSX are $956.10 million, and the net expense ratio is 1.05. Thermo Fisher Scientific, UnitedHealth Group, and Eli Lilly and Company are the top three holdings in the portfolio.

9. Rowe Price Health Sciences Fund (PRHSX, 50%)

PRHSX makes investments in businesses that are involved in the research, development, distribution, or manufacturing of health-related products or services. In the previous three years, this fund has provided a return of 18.72 percent, and in the previous five years, it has given a return of 17.23 percent. PRHSX has a net expense ratio of 0.76 and a total asset value of $17.69 billion. UnitedHealth Group, Thermo Fisher Scientific, and Intuitive Surgical are the top three stocks in the fund’s portfolio.

Lord Abbett Health Care Fund (LHCAX, 52%)

LHCAX is a healthcare-related stock exchange that invests in equities and equity-related securities. In the previous six months, this fund has provided a 12 percent return. The total assets of LHCAX are $7.03 million, with a net expense ratio of 1.03. Abbott Laboratories, Eli Lilly and Company, and UnitedHealth Group are the fund’s top three holdings.

Fidelity® Select Biotechnology Portfolio (FBIOX, 55%)

FBIOX generally invests in firms that are involved in biotech and related product research, development, production, and distribution. In the previous three years, this fund has returned 15.93 percent, and in the previous five years, it has returned 16.96 percent. The total assets of FBIOX are $8.31 billion, with a net expense ratio of 0.72. AbbVie, Vertex Pharmaceuticals, and Biogen are the fund’s top three holdings.

Fidelity® Select Medical Tech&Devcs Port (FSMEX, 56%)

FSMEX invests in companies that work in the fields of medical equipment and associated technologies research, development, production, distribution, and sale. In the previous three years, this fund has returned 24.12 percent, and in the previous five years, it has returned 23.14 percent. The total assets of FSMEX are $8.66 billion, with a net expense ratio of 0.71. Thermo Fisher Scientific, Danaher, and Boston Scientific are the fund’s top three holdings.

PGIM Jennison Health Sciences Fund (PHLAX, 57%)

PHLAX invests in the stock and stock-related securities of companies in the health sciences industry. In the previous three years, this fund has returned 15.36 percent, and in the previous five years, it has returned 16.30 percent. The total assets of PHLAX are $2.26 billion, with a net expense ratio of 1.14. UnitedHealth, Eli Lilly and Company, and Natera are the fund’s top three holdings.

Baron Health Care Fund (BHCHX, 64%)

BHCHX invests in the common stock of companies that are involved in the research, development, manufacturing, sale, delivery, or distribution of health-related products and services. In the previous six months, this fund has yielded an 18 percent return. BHCHX has a net expense ratio of 0.85 and a total asset value of $126.9 million. UnitedHealth, Icon, and Thermo Fisher Scientific are the top three holdings in the portfolio.

Eventide Healthcare & Life Sciences Fund (ETAHX, 65%)

ETAHX invests in equities and equity-related securities of companies in the healthcare and life sciences industries during normal business hours. In the previous three years, this fund has returned 28.39 percent, and in the previous five years, it has returned 26.06 percent. ETAHX has a total asset value of $2.16 billion and a net expense ratio of 1.55. First American Government Obligations U, Biohaven Pharmaceutical, and Ascendis Pharmaceutical are the fund’s top three holdings.

AlphaCentric LifeSci Healthcare Fund (LYFAX, 67%)

LYFAX is a mutual fund that invests in the stock of firms in the life sciences and healthcare industries. In the previous six months, this fund has provided a 30 percent return. LYFAX has a total asset value of $28.22 million and a net expense ratio of 1.65. Viracta Therapeutics, Gilead Sciences, and Athira Pharma are the fund’s top three holdings.

Perkins Discovery Fund (PDFDX, 169%)

PDFDX typically invests in domestic equities securities with a market valuation of less than $1 billion. In the previous three years, this fund has returned 37.76 percent, and in the previous five years, it has returned 31.08 percent. PDFDX has a net expense ratio of 2.61 and total assets of $25.13 million. Magnite, Vericel, and Natera are the fund’s top three holdings.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

48  +    =  52